Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis

Multiple sclerosis (MS) is considered to be a central nervous system (CNS) chronic inflammatory demyelinating disease, affecting more than 2 million individuals worldwide. In this meta-analysis, we aimed to assess the safety and efficacy of autologous mesenchymal stem cells (aMSCs) in treating MS pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Zhou, Xin Zhang, Hang Xue, Lingling Liu, Jie Zhu, Tao Jin
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/8536785
Tags: Add Tag
No Tags, Be the first to tag this record!